Open Payments

MENG CHEN

Type
Physician · Allopathic & Osteopathic Physicians / Allergy & Immunology
Where
ATHERTON, CA
NPI
1497190714
Received
$7,873 in 65 records, 2019 to 2025
As principal investigator
$223,118 of research payments to others in 59 records
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2025General payment10$263
2024General payment4$130
2023General payment4$1,440
2022General payment1$97
2021General payment16$253
2020General payment5$207
2019General payment25$5,481

By company

CompanyRecordsAmountYears
Genentech, Inc.6$5,0512019
GlaxoSmithKline, LLC.20$1,5022019–2025
GENZYME CORPORATION7$3772019–2024
Novartis Pharmaceuticals Corporation9$2562019–2025
Genentech USA, Inc.6$2152019–2024
COLOPLAST CORP2$1182023
Boehringer Ingelheim Pharmaceuticals, Inc.1$1022021
Regeneron Healthcare Solutions, Inc.3$562019
Arcutis Biotherapeutics, Inc.2$412024–2025
Optinose US, Inc.3$402019
AstraZeneca Pharmaceuticals LP2$332019–2023
PFIZER INC.1$232019
kaleo, Inc.1$182019
ALK-Abello, Inc1$182019
Shire North American Group Inc1$162019

By nature of payment

NatureRecordsAmount
Travel and Lodging3$3,358
Consulting Fee2$1,613
Food and Beverage59$1,601
Compensation for services other than consulting, including serving as faculty or as a speaker at a v1$1,300

Records

DateCompanyAmountNatureFormProductStudyYear
2025-11-03Novartis Pharmaceuticals Corporation$31Food and BeverageIn-kind items and servicesRhapsido Drug, Immunology2025
2025-10-16Novartis Pharmaceuticals Corporation$25Food and BeverageIn-kind items and servicesRhapsido Drug, Immunology2025
2025-09-15Novartis Pharmaceuticals Corporation$17Food and BeverageIn-kind items and servicesXOLAIR Drug, Pulmonary/Respiratory Diseases2025
2025-07-29Novartis Pharmaceuticals Corporation$24Food and BeverageIn-kind items and services2025
2025-07-25Novartis Pharmaceuticals Corporation$75Food and BeverageIn-kind items and services2025
2025-06-11Arcutis Biotherapeutics, Inc.$14Food and BeverageIn-kind items and servicesZoryve Drug, Dermatology2025
2025-06-02Novartis Pharmaceuticals Corporation$17Food and BeverageIn-kind items and servicesXOLAIR Drug, Pulmonary/Respiratory Diseases2025
2025-04-29Novartis Pharmaceuticals Corporation$18Food and BeverageIn-kind items and servicesXOLAIR Drug, Pulmonary/Respiratory Diseases2025
2025-02-05Novartis Pharmaceuticals Corporation$23Food and BeverageIn-kind items and servicesXOLAIR Drug, Pulmonary/Respiratory Diseases2025
2025-01-14GlaxoSmithKline, LLC.$16Food and BeverageIn-kind items and servicesTRELEGY ELLIPTA Drug, RESPIRATORY2025
2024-12-17Arcutis Biotherapeutics, Inc.$26Food and BeverageIn-kind items and servicesZoryve Drug, Dermatology2024
2024-12-04GlaxoSmithKline, LLC.$16Food and BeverageIn-kind items and servicesAREXVY Drug, RESPIRATORY2024
2024-05-08Genentech USA, Inc.$21Food and BeverageIn-kind items and servicesXolair Biological, Immunology2024
2024-02-06GENZYME CORPORATION$65Food and BeverageIn-kind items and servicesDUPIXENT Biological, Immunology2024
2023-08-09AstraZeneca Pharmaceuticals LP$21Food and BeverageIn-kind items and servicesBREZTRI Drug, Respiratory2023
2023-04-11COLOPLAST CORP$78Food and BeverageIn-kind items and servicesTitan Device, Men's Health2023
2023-04-04COLOPLAST CORP$40Food and BeverageIn-kind items and servicesTitan Device, Men's Health2023
2023-03-03GlaxoSmithKline, LLC.$1,300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentNUCALA Biological, IMMUNOLOGY2023
2022-12-07GENZYME CORPORATION$97Food and BeverageIn-kind items and services2022
2021-12-23GlaxoSmithKline, LLC.$1Food and BeverageIn-kind items and servicesNUCALA Biological, IMMUNOLOGY2021
2021-11-04GlaxoSmithKline, LLC.$6Food and BeverageIn-kind items and servicesNUCALA Biological, IMMUNOLOGY2021
2021-10-21GlaxoSmithKline, LLC.$12Food and BeverageIn-kind items and servicesNUCALA Biological, IMMUNOLOGY2021
2021-10-19GlaxoSmithKline, LLC.$4Food and BeverageIn-kind items and servicesNUCALA Biological, IMMUNOLOGY2021
2021-10-13Boehringer Ingelheim Pharmaceuticals, Inc.$102Food and BeverageIn-kind items and services2021
2021-09-30GlaxoSmithKline, LLC.$5Food and BeverageIn-kind items and servicesNUCALA Biological, IMMUNOLOGY2021
2021-09-29GlaxoSmithKline, LLC.$16Food and BeverageIn-kind items and servicesNUCALA Biological, IMMUNOLOGY2021
2021-09-15Genentech USA, Inc.$20Food and BeverageIn-kind items and servicesXolair Biological, Immunology2021
2021-09-07GlaxoSmithKline, LLC.$8Food and BeverageIn-kind items and servicesNUCALA Biological, IMMUNOLOGY2021
2021-08-31GlaxoSmithKline, LLC.$4Food and BeverageIn-kind items and servicesNUCALA Biological, IMMUNOLOGY2021
2021-08-19GlaxoSmithKline, LLC.$4Food and BeverageIn-kind items and servicesNUCALA Biological, IMMUNOLOGY2021
2021-08-11GlaxoSmithKline, LLC.$23Food and BeverageIn-kind items and servicesNUCALA Biological, IMMUNOLOGY2021
2021-07-28GlaxoSmithKline, LLC.$23Food and BeverageIn-kind items and servicesNUCALA Biological, IMMUNOLOGY2021
2021-07-23GlaxoSmithKline, LLC.$13Food and BeverageIn-kind items and servicesNUCALA Biological, IMMUNOLOGY2021
2021-06-18GlaxoSmithKline, LLC.$1Food and BeverageIn-kind items and servicesNUCALA Biological, IMMUNOLOGY2021
2021-05-14GlaxoSmithKline, LLC.$2Food and BeverageIn-kind items and servicesNUCALA Biological, IMMUNOLOGY2021
2020-06-16GENZYME CORPORATION$24Food and BeverageIn-kind items and servicesDUPIXENT Biological, Immunology2020
2020-04-21Genentech USA, Inc.$21Food and BeverageIn-kind items and servicesXolair Biological, Immunology2020
2020-03-03GlaxoSmithKline, LLC.$13Food and BeverageIn-kind items and servicesNUCALA Biological, RESPIRATORY2020
2020-01-23GENZYME CORPORATION$125Food and BeverageIn-kind items and servicesDUPIXENT Biological, Immunology2020
2020-01-22GENZYME CORPORATION$23Food and BeverageIn-kind items and servicesDUPIXENT Biological, Immunology2020
2019-12-09GlaxoSmithKline, LLC.$12Food and BeverageIn-kind items and servicesNUCALA Biological, RESPIRATORY2019
2019-11-08Genentech, Inc.$79Food and BeverageIn-kind items and servicesXolair Biological, Immunology2019
2019-11-07Genentech USA, Inc.$28Food and BeverageIn-kind items and services2019
2019-11-05GENZYME CORPORATION$21Food and BeverageIn-kind items and servicesDUPIXENT Drug, IMMUNOLOGY2019
2019-07-16kaleo, Inc.$18Food and BeverageIn-kind items and servicesAUVI-Q Drug, ALLERGY2019
2019-07-09PFIZER INC.$23Food and BeverageIn-kind items and servicesEUCRISA Drug, DERMATOLOGY2019
2019-06-20Genentech, Inc.$1,419Consulting FeeCash or cash equivalentXolair Biological, Immunology2019
2019-06-20Genentech, Inc.$765Travel and LodgingCash or cash equivalentXolair Biological, Immunology2019
2019-06-18Optinose US, Inc.$13Food and BeverageIn-kind items and servicesXhance Drug, Otolaryngology (Ear, Nose, Throat)2019
2019-06-04Regeneron Healthcare Solutions, Inc.$17Food and BeverageIn-kind items and servicesDUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY2019
2019-05-28Optinose US, Inc.$15Food and BeverageIn-kind items and servicesXhance Drug, Otolaryngology (Ear, Nose, Throat)2019
2019-05-07Regeneron Healthcare Solutions, Inc.$21Food and BeverageIn-kind items and servicesDUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY2019
2019-04-17Shire North American Group Inc$16Food and BeverageIn-kind items and servicesCINRYZE Drug, IMMUNOLOGY2019
2019-04-16GlaxoSmithKline, LLC.$13Food and BeverageIn-kind items and servicesNUCALA Biological, RESPIRATORY2019
2019-04-03Genentech USA, Inc.$107Food and BeverageIn-kind items and servicesXolair Biological, Immunology2019
2019-04-03Regeneron Healthcare Solutions, Inc.$17Food and BeverageIn-kind items and servicesDUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY2019
2019-03-26Optinose US, Inc.$12Food and BeverageIn-kind items and servicesXhance Drug, Otolaryngology (Ear, Nose, Throat)2019
2019-03-01Genentech, Inc.$2,185Travel and LodgingCash or cash equivalentXolair Biological, Immunology2019
2019-02-22Genentech, Inc.$406Travel and LodgingCash or cash equivalentXolair Biological, Immunology2019
2019-02-22Genentech, Inc.$193Consulting FeeCash or cash equivalentXolair Biological, Immunology2019
2019-02-12AstraZeneca Pharmaceuticals LP$12Food and BeverageIn-kind items and servicesFASENRA Drug, Respiratory2019
2019-02-05ALK-Abello, Inc$18Food and BeverageIn-kind items and servicesOdactra Drug, Allergy and Immunology2019
2019-01-30GENZYME CORPORATION$20Food and BeverageIn-kind items and servicesDUPIXENT Drug, IMMUNOLOGY2019
2019-01-08Novartis Pharmaceuticals Corporation$24Food and BeverageIn-kind items and servicesXOLAIR Biological, RESPIRATORY2019
2019-01-08Genentech USA, Inc.$16Food and BeverageIn-kind items and servicesXolair Biological, Immunology2019

Research payments naming this person as principal investigator

DateCompanyPaid toAmountStudyYear
2021-09-21Aimmune Therapeutics, Inc.Leland Stanford Junior University$40,026A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2021
2021-06-08Aimmune Therapeutics, Inc.Leland Stanford Junior University$23,122A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2021
2021-03-23Aimmune Therapeutics, Inc.Leland Stanford Junior University$211A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2021
2021-03-23Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2021
2021-03-23Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2021
2021-03-23Aimmune Therapeutics, Inc.Leland Stanford Junior University$140A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2021
2021-03-23Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2021
2021-03-23Aimmune Therapeutics, Inc.Leland Stanford Junior University$140A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2021
2021-03-23Aimmune Therapeutics, Inc.Leland Stanford Junior University$140A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2021
2021-03-23Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2021
2021-03-23Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2021
2021-03-09Aimmune Therapeutics, Inc.Leland Stanford Junior University$21,431A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2021
2020-12-31Aimmune Therapeutics, Inc.Leland Stanford Junior University$18A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-12-15Aimmune Therapeutics, Inc.Leland Stanford Junior University$27,570A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-09-08Aimmune Therapeutics, Inc.Leland Stanford Junior University$14,626A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$1,696A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$1,696A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$1,696A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$53A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$53A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$1,696A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$1,696A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$1,696A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-14Aimmune Therapeutics, Inc.Leland Stanford Junior University$70A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-07-01Aimmune Therapeutics, Inc.Leland Stanford Junior University$36,218A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-03-11Aimmune Therapeutics, Inc.Leland Stanford Junior University$46,439A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

San Mateo CountyAtherton town

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Atherton, CA, county San Mateo County, CA, state California; placed by its city name.

MeasurePlace (city or town)
Atherton, CA
County
San Mateo County, CA
State
California
Population B010036,993742,34039,287,377
Population, 2020 census P17,188764,44239,538,223
Median age B0100249.140.937.9
Under 18 B0100118.4%19.5%22.0%
65 and over B0100125.6%17.8%15.7%
Households B110012,227264,41913,548,091
Foreign born B0500220.5%35.7%27.0%
Median household income B19013$250,001$158,855$99,122
Median family income B19113$250,001$189,508$113,346
Per capita income B19301$188,631$84,288$49,513
Poverty rate B170015.3%6.7%12.0%
Unemployment rate B230253.2%4.8%6.6%
Civilian labor force B230252,846413,18920,068,466
Mean commute (minutes) B0801323.226.428.7
Bachelor's degree or higher B1500383.1%53.7%37.1%
Housing units B250012,667287,18414,644,735
Owner-occupied B2500387.6%58.5%55.9%
Renters B2500312.4%41.5%44.1%
Median home value B25077$2,000,001$1,559,600$734,700
Median gross rent B25064$3,501$2,922$2,036
White, not Hispanic B0300262.0%34.7%33.8%
Black B030020.9%2.0%5.2%
Hispanic or Latino B0300214.2%24.9%40.2%
Asian B0300218.0%31.0%15.3%
American Indian and Alaska Native B030020.0%0.1%0.3%

Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); Unemployment rate: 5.5% in Sep 2016 to 5.1% in Sep 2026; low 3.8%, high 16.1% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Atherton, CA.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.